Katie J. Rolfe
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Randomized, Placebo-Controlled, First-in-Human Study of the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Oral Doses of Novel Antitubercular Drug Candidate, GSK2556286, in Healthy Adults.
Journal: Journal of clinical pharmacology
Published: December 22, 2025
Combined Oral Contraceptive Drug-Drug Interaction Study With Ganfeborole, a New Anti-Tuberculosis Agent.
Journal: Journal of clinical pharmacology
Published: August 08, 2025
Designing a response-over-continuous-intervention (ROCI) randomised trial: Implementation in the Phase 2C part (duration ranging) of the PARADIGM4TB trial.
Journal: Contemporary clinical trials
Published: January 14, 2025
An observational pilot study of an active surveillance tool to enhance pharmacovigilance in Brazil.
Journal: Malaria journal
Published: July 10, 2024
Tafenoquine for the radical cure versus prophylaxis of Plasmodium vivax malaria: the importance of using the appropriate data set.
Journal: The Indian journal of medical research
Published: September 07, 2023
Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
Optimal balance of benefit versus risk for tafenoquine in the treatment of Plasmodium vivax malaria.
Journal: Malaria journal
Published: August 31, 2023
Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'.
Journal: eLife
Published: June 07, 2023
A flexible multi-metric Bayesian framework for decision-making in Phase II multi-arm multi-stage studies.
Journal: Statistics in medicine
Published: February 15, 2023
Tafenoquine co-administered with dihydroartemisinin-piperaquine for the radical cure of Plasmodium vivax malaria (INSPECTOR): a randomised, placebo-controlled, efficacy and safety study.
Journal: The Lancet. Infectious diseases
Published: October 31, 2022
A pharmacometrics approach to assess the feasibility of capillary microsampling to replace venous sampling in clinical studies: Tafenoquine case study.
Journal: British journal of clinical pharmacology
Published: March 18, 2022
Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
Journal: The Lancet. Child & adolescent health
Published: July 26, 2021
Neuromuscular reinnervation efficacy using a YFP model.
Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS
Published: February 10, 2020
Last Updated: 09/26/2026